On Monday, Ocular Therapeutix Inc (NASDAQ: OCUL) opened higher 5.22% from the last session, before settling in for the closing price of $11.3. Price fluctuations for OCUL have ranged from $5.78 to $13.85 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 8.51% over the past five years. Company’s average yearly earnings per share was noted -18.85% at the time writing. With a float of $188.09 million, this company’s outstanding shares have now reached $213.05 million.
Ocular Therapeutix Inc (OCUL) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ocular Therapeutix Inc is 11.72%, while institutional ownership is 79.01%. The most recent insider transaction that took place on Nov 05 ’25, was worth 277,790. In this transaction Chief Business Officer of this company sold 25,865 shares at a rate of $10.74, taking the stock ownership to the 174,135 shares. Before that another transaction happened on Nov 05 ’25, when Company’s Officer proposed sale 25,865 for $10.74, making the entire transaction worth $277,909.
Ocular Therapeutix Inc (OCUL) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.29 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.22) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -18.85% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.57% during the next five years compared to 8.51% growth over the previous five years of trading.
Ocular Therapeutix Inc (NASDAQ: OCUL) Trading Performance Indicators
Check out the current performance indicators for Ocular Therapeutix Inc (OCUL). In the past quarter, the stock posted a quick ratio of 7.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 45.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.44, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.37 in one year’s time.
Technical Analysis of Ocular Therapeutix Inc (OCUL)
Ocular Therapeutix Inc (NASDAQ: OCUL) saw its 5-day average volume 2.62 million, a positive change from its year-to-date volume of 2.07 million. As of the previous 9 days, the stock’s Stochastic %D was 75.32%.
During the past 100 days, Ocular Therapeutix Inc’s (OCUL) raw stochastic average was set at 59.25%, which indicates a significant decrease from 88.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.53 in the past 14 days, which was lower than the 0.57 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.78, while its 200-day Moving Average is $9.69. Nevertheless, the first resistance level for the watch stands at $12.25 in the near term. At $12.62, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.20. If the price goes on to break the first support level at $11.30, it is likely to go to the next support level at $10.72. Assuming the price breaks the second support level, the third support level stands at $10.35.
Ocular Therapeutix Inc (NASDAQ: OCUL) Key Stats
There are currently 213,047K shares outstanding in the company with a market cap of 2.53 billion. Presently, the company’s annual sales total 63,720 K according to its annual income of -193,510 K. Last quarter, the company’s sales amounted to 14,540 K and its income totaled -69,420 K.
